Cd20 binding molecules

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01)

Patent

CA 2525139

The present invention relates to CD20 binding molecules and nucleic acid sequences encoding CD20 binding molecules. In particular, the present invention relates to CD20 binding molecules with a high binding affinity, and a low dissociation rate, with regard to human CD20. Preferably, the CD20 binding molecules of the present invention comprise light and/or heavy chain variable regions with fully human frameworks (e.g. human germline frameworks).

L'invention concerne des molécules de liaison de CD20 et des séquences d'acide nucléique codant les molécules de liaison de CD20. En particulier, l'invention concerne des molécules de liaison de CD20 comprenant une affinité de liaison élevée, et un taux de dissociation faible, par rapport aux CD20 humains. De préférence les molécules de liaison de CD20 de l'invention comprennent des régions variable à chaînes légères et/ou lourdes avec des infrastructures complètement humaines (par exemple des infrastructures humaines germinales).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cd20 binding molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cd20 binding molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd20 binding molecules will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1876163

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.